Do you have idiopathic gastroparesis?
If so, consider joining envision GI study, an idiopathic gastroparesis clinical trial researching an investigational delayed gastric emptying treatment option.
What is the Envision GI study?
The Envision GI study is a clinical research study for people who have been diagnosed with idiopathic gastroparesis.
The main purpose of this study is to find out how well the study medication (CIN-102, deudomperidone) improves the
symptoms associated with idiopathic gastroparesis.
Who can join the study?
You may be able to join the study if you meet the following requirements:
Age 18 or older
Confirmed diagnosis of idiopathic gastroparesis
Gastrointestinal symptoms within the last 6 months such as:
Nausea or vomiting after eating
Feeling too full after eating
Bloating
Throat or stomach pain
Other criteria apply. Talk to your doctor to learn more.